MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
NERV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Minerva Neurosciences (NERV) Ownership - Who owns Minerva Neurosciences?

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
1500 District Avenue
Phone
+1 617 600-7373
Employees
7
Web
https://www.minervaneurosciences.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
217.57M
P/E Ratio
2.57
Total Cash
78.06M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.64
Dividend Yield
N/A
Total Cash/Share
1.68
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
NERV
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for NERV
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
1500 District Avenue
Phone
+1 617 600-7373
Employees
7
Web
https://www.minervaneurosciences.com